Science and Discovery

Drug Competition

1 article

Scientist in a futuristic lab analyzing a GLP-1 drug vial with holographic displays showing molecular structures and patient data.
Cosmos & Space

Medicare offers $50 monthly GLP-1 access amid obesity drug competition

Starting July 1, 2026, eligible Medicare beneficiaries will pay just $50 a month for certain GLP-1 obesity drugs.

Marcus Cole·June 8, 2026